Skip to main content
Caplight Logo









Restera

Restera

Private
Santa Clara, CaliforniaConsumer & Commercehttps://www.resterasleep.com/

Last Round

Series A

Jun 1, 2023

Total Funding Raised

$81.33M

Company Overview

Restera is a medical technology company developing an intelligent neurostimulation system for the treatment of obstructive sleep apnea.

Sector

Consumer & Commerce

Verticals

D2C Brands, E-commerce, Home & Lifestyle

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceneurostimulationsleep apnea treatmentimplantable devicemedtechobstructive sleep apneaOSAclinical-stagetherapeutic devicemedical hardwaresleep medicinesurgical implantbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Restera Comparables

Compare Restera with similar companies based on industry and business-model similarity.

Restera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeus Sleep Ltd
34%
Signifier Medical Technologies
34%

Restera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2023
Series CApr 21, 2023
Series BNov 12, 2021
Series BDec 21, 2017
Series AJun 29, 2016

Restera Investors

Notable investors and investment history

Restera investors
InvestorRounds
Forepont Capital PartnersSeries A, Series B, Series C
Aphelion CapitalSeries A, Series B, Series C
Thiel CapitalSeries B
GreatPoint VenturesSeries A, Series B
Innovation FactorySeries C
Eclipse VenturesSeries B
Seraph GroupSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2023

    $25M round led by Aphelion Capital and Bonit Capital.

Restera Filings

Explore SEC and related filing metadata, where available.

Restera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Restera's valuation, stock price, and market status.

Is Restera a public or private company?

Restera is a private company.

What is the current stock price of Restera?

Restera is a private company with no public stock price. No recent secondary market data is available.

How much is Restera worth (valuation)?

Valuation information for Restera is not publicly available.

Can I buy Restera stock?

Restera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Restera's last funding round?

Restera's most recent funding round was Series A on June 1, 2023.

Who are the main investors in Restera?

Key investors in Restera include Forepont Capital Partners, Aphelion Capital, Thiel Capital, GreatPoint Ventures, Innovation Factory.

Will Restera IPO soon?

No public IPO plans have been announced for Restera.

How can I track Restera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Restera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range8
Year Founded2013
Last FundingJun 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?